Inventor
MATTHEW COOPER
Inventor
GB
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds23%
A61KPreparations for medical, dental or toiletry purposes16%
C07CAcyclic or carbocyclic compounds5%
C07KPeptides5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C12NMicroorganisms or enzymes4%
C12YEnzymes3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology1%
PatentTitleYear
12,564,648Gene editing of CAR-T cells for the treatment of T cell malignancies with chimeric antigen receptors202612,548,962Active transverse mode instability mitigation for high power fiber amplifiers apparatus, methods, and applications202612,350,349Gene editing of CAR-T cells for the treatment of T cell malignancies with chimeric antigen receptors202512,304,941Suppression of cytokine release syndrome in chimeric antigen receptor cell therapy202512,221,434Sulfonamide carboxamide compounds202512,187,702Sulfonamideurea compounds202512,168,653Sulfonamide derivates as NLRP3 inhibitors202412,030,879Sulfonyl acetamides as NLRP3 inhibitors202412,012,392Sulfonamide carboxamide compounds202411,981,667Sulfonamide carboxamide compounds2024D1023679Bottle with handle202411,926,600Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors202411,905,252Compounds202411,884,645Sulfonyl acetamides as NLRP3 inhibitors202411,858,922Sulfonylureas and related compounds and use of same202411,840,543Compounds and uses202311,834,433Compounds202311,613,542Sulfonylureas and sulfonylthioureas as NLRP202311,542,255Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors202311,530,200Compounds202211,465,992Sulfonamide carboxamide compounds202211,370,776Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors202211,333,672Preeclampsia biomarkers and related systems and methods202211,279,733Peptide antibiotics2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to INFLAZOME LTD (15)· patent assignee history
2022–2024Patents assigned to UNIV QUEENSLAND (3)· patent assignee history
2022–2025Based in GB· patent location history
2022–2026Based in US· patent location history
2022–2024Based in AU· patent location history
2023–2024Patents assigned to PROVOST FELLOWS FOUND SCHOLARS & OTHER MEMBERS BOARD COLLEGE HOLY & UND (2)· patent assignee history
2024Patents assigned to BOXING CLEVER LONDON LTD (1)· patent assignee history
2025–2026Patents assigned to WASHINGTON UNIVERSITY ST LOUIS (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INFLAZOME LTD | 15 | 2022–2025 |
| UNIV QUEENSLAND | 3 | 2022–2024 |
| WASHINGTON UNIVERSITY ST LOUIS | 3 | 2025–2026 |
| PROVOST FELLOWS FOUND SCHOLARS & OTHER MEMBERS BOARD COLLEGE HOLY & UND | 2 | 2023–2024 |
| BOXING CLEVER LONDON LTD | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| GB | 16 | 2022–2025 |
| US | 5 | 2022–2026 |
| AU | 3 | 2022–2024 |